Autoimmune
Optimizing Pharmacotherapy In Chronic GVHD
Chronic graft-versus-host disease can occur in a multitude of organs, often characterized by fibrosis or ...
JUNE 13, 2025
Fresenius Launches Subcutaneous Formulation of Tyenne, Biosimilar to Tocilizumab
Fresenius, via its operating company Fresenius Kabi, announced the immediate availability in the United States of ...
JULY 10, 2024
Understanding the Link Between CVD and Treatment for Autoimmune Rheumatic Diseases
The immunosuppressants used to treat autoimmune rheumatic diseases often cause changes to cell metabolism and ...
JANUARY 19, 2022
Load more